With recent developments in the fields of drug delivery and medical imaging, nanotechnology is rapidly moving out of the lab, into the commercialization phase. During the economic downturn, nanotech has remained a growth area, but research funding has increasingly been linked with commercialization, and academics have turned to the opportunities presented by startup launches and the interest venture capital has been taking in nanomedicine. Chan and Das can both boast the combination of academic backgrounds and successful commerial ventures, and have written this book to provide a both a routemap to business success and a toolkit for academics and researchers seeking to leverage research funding and venture capital. With a scientific rigor missing from many ‘nanobusiness’ books, they describe the current trends in nanomedicine at universities and examine how their developments and discoveries are being translated into real-world products that are expected to have great impact in health care. They discuss nanotechnology-based drug carriers and diagnostics, the value chain for nanomedicine businesses, the intellectual property landscape, and strategies for the commercialization of Nanomedicine products. There is currently tremendous interest and growth in the funding of Nanomedicine-based projects, number of start-up companies in the field, and intellectual properties filed. However, this is the first book-length study of the interface between nanomedicine and the commercial world. Chan and Das provide a much needed guide for the entrepreneurial scientist and entrepreneur interested in investing in emerging nanotechnologies for medicine. Chan and Das share their experience of successfully bridging the academic and commercial worlds, providing both academics and entrepreneurs with the toolkit they need to identify research developments with commercial potential and launch and run a successful startup. Readers will gain an understanding of the trends in the emerging technologies of nanomedicine, the regulatory environment, and the business developments that have caused commentators to describe nanotechnology as ‘the new industrial revolution’. Academics and Researchers will learn how to harness research funding and venture capital for the more rapid development of their research work. Case studies provide real world examples of the commercialization of nanomedicine.